BRTX
BRTX
NASDAQ · Biotechnology

Biorestorative Therapies Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$0.19
+0.00 (+1.75%)
As of May 16, 2:31 AM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +13,516.0% upside
Low Target $18.72
Average Target $26.17
High Target $39.89
Current Price $0.19
Current
$0.19
Target
$26.17
$18.72 $26.17 avg $39.89
Scenario Analysis
Bear Case
$18.72
9,639.9%
Low target
Base Case
$26.17
+13,516.0%
Avg target
Bull Case
$39.89
+20,654.4%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$2.05
-90.6% from high
52-Week Low
$0.17
+10.3% from low
Target vs 52W High
$26.17
+1,179.7% vs high
Next Earnings Report
May 20, 2026
3d
until earnings
EPS Est: $-0.20
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
 Buy 43 56% $91.45 -52.6%